Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortTwice-daily blood thinner without routine monitoring.Classic blood thinner monitored by INR tests.
Body systemBlood & ClottingBlood & Clotting
Drug classDirect oral anticoagulantsVitamin K antagonists
SupplyPrescription onlyPrescription onlyWHO essential medicine
Main usesStroke prevention in atrial fibrillation, Deep vein thrombosis and pulmonary embolism, Clot prevention after hip or knee replacementAtrial fibrillation stroke prevention, Deep vein thrombosis and pulmonary embolism, Mechanical heart valves
How it worksBlocks one key clotting protein directly.Stops the liver using vitamin K to make clotting proteins.
Starts working3–4 hoursFull effect takes 3–5 days
Half-lifeAbout 12 hours20–60 hours (average ~40)
Typical adult doseAF: 5 mg twice a day (2.5 mg if two of: age ≥80, weight ≤60 kg, poor kidney function). Clot treatment: 10 mg twice a day for 7 days, then 5 mg twice a day.Individual — adjusted to keep INR usually between 2 and 3 (higher for some valves).
FormsTabletTablet (colour-coded strengths)
Common side effectsBruising, Nosebleeds, Heavy periodsBruising, Nosebleeds, Bleeding gums
Serious side effectsMajor bleeding, Bleeding in the brain (less than with warfarin)Major bleeding (blood in urine or stool, vomiting blood, severe headache), Skin necrosis (rare)
Don't take ifActive major bleeding; Severe liver disease with clotting abnormalities; Mechanical heart valve; Taking strong CYP3A4 and P-gp inhibitors (ketoconazole, ritonavir) without reviewPregnancy (especially first trimester); Active bleeding or severe bleeding risk; Severe liver disease; Recent major surgery or stroke with bleeding
AlcoholBest to limit. Alcohol raises bleeding risk.Best to limit. Binge drinking changes INR unpredictably and increases bleeding risk; keep intake modest and consistent.
PregnancyUsually avoidedNot used in pregnancy; low-molecular-weight heparin is preferred.Usually avoidedCauses birth defects in the first trimester; heparin is used instead.
BreastfeedingUsually avoidedAvoid.Generally considered safeSafe while breastfeeding.
In use since20121954
Brand namesUnited States: EliquisUnited Kingdom: EliquisIndia: Eliquis, ApigatUnited States: Coumadin, JantovenUnited Kingdom: MarevanIndia: Warf, Uniwarfin
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeB01AF02B01AA03

Taken together

  • MajorApixaban + Warfarin: Double anticoagulation — serious bleeding risk

    Two blood thinners together greatly increase the risk of major bleeding.

Open in the interaction checker